Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: A randomised double-blind parallel-group placebo-controlled study in Australian men|
|Citation:||International Journal of Clinical Practice, 2005; 59(2):143-149|
|C.G. McMahon, B.G.A. Stuckey, D.W. Lording, G.A. Wittert, A. Murphy, J. Shin, P.D. Sutherland, N.R. Palmer, M.P. Lowy, D.R. Jesudason, P. Fredlund|
|Abstract:||The efficacy and safety of tadalafil for the treatment of erectile dysfunction (ED) were assessed in a 6-month, randomised, double-blind, placebo-controlled study. Australian men with mild, moderate or severe ED of organic, psychogenic or mixed aetiology were randomised to tadalafil 20 mg as needed (n = 93) or placebo (n = 47). Efficacy assessments included the international index of erectile function (IIEF) and the sexual encounter profile (SEP) diary. Tadalafil significantly improved erectile function compared with placebo (p < 0.001, all measures). At the end of the study, the mean per-patient proportion of successful sexual intercourse attempts (SEP question three) was 73.5% for patients treated with tadalafil and 26.8% for placebo-treated patients. Improved erections were reported by 78% of tadalafil-treated patients compared to 12.8% of placebo-treated patients. The most common treatment-emergent adverse events--headache and dyspepsia--were generally mild or moderate. Tadalafil was effective and well tolerated in Australian men with mild to severe ED.|
|Keywords:||Humans; Carbolines; Phosphodiesterase Inhibitors; Treatment Outcome; Double-Blind Method; Adult; Aged; Middle Aged; Australia; Male; Erectile Dysfunction; Tadalafil|
|Description:||The definitive version is available at www.blackwell-synergy.com|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.